PipeBio

Acquired

PipeBio is a SaaS bioinformatics platform to develop antibody drugs.

Aarhus, Denmark · Founded 2020 · $316K raised

Headquarters
Aarhus
Employees
1–10
Founded
2020
Total Funding
$316K
Last Round
$316K SeedJan 2021
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 4 investors for this company. The full record is or through the API.

About

Pipe|bio is the bioinformatics cloud for antibody / peptide screening & drug development. We enable scientists to analyze and manage massive amounts of DNA sequencing data themselves without the need for bioinformaticians or programmers. The software is highly visual and enables you to overlay and filter information from different sources across your organization; be it assay data, sequence data or other process metadata. Insights from past results can be used to guide new experiments and they get better as you upload more and more data. Team leads get oversight and these capabilities combined empower organizations to find better drugs, faster. We believe that science moves faster when scientists can curate and analyse their own data.

Summary

PipeBio is a Drug Discovery company based in Aarhus, Denmark, founded in 2020. It has raised $316K in total across 1 round, most recently a $316K Seed round in Jan 2021. Investors include Y Combinator, Acequia Capital and byFounders.

Tech & App Stack

9 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed Round2021 (est.)
$316K

Investors

Similar Companies

EdifecsAcquired

Edifecs delivers healthcare technology that unifies data for nearly 300 million people, powering ...

Bellevue, United States1001–5000Artificial Intelligence, Healthcare
Growth EquityTotal funding$1.4BJul 2020
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Biotech
Series DTotal funding$1.1BFeb 2025
Xaira Therapeutics

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...

South San Francisco, United States51–200Artificial Intelligence, Biotech
Series ATotal funding$1.0BApr 2024
Shields Health Solutions

The nation's first company to integrate specialty pharmacies into hospitals and health systems, h...

United StatesHealthcare, Drug Discovery
Corporate RoundTotal funding$3.5BSep 2025
Devoted Health

Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Waltham, United States1001–5000Artificial Intelligence, Healthcare
Series G+Total funding$3.5BOct 2026
Verily Life Sciences

Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...

Dallas, United States1001–5000Artificial Intelligence, Healthcare
Corporate RoundTotal funding$3.0BMar 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

PipeBio on Indexed.vc
<a href="https://indexed.vc/companies/pipebio"><img src="https://indexed.vc/api/badge/company/pipebio" alt="PipeBio on Indexed.vc" width="260" height="76" /></a>